Global Mosapride Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Mosapride Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Mosapride is a gastroprokinetic agent that acts as a selective 5HT4 agonist. The major active metabolite of mosapride, known as M1, additionally acts as a 5HT3 antagonist,which accelerates gastric emptying throughout the whole of the gastrointestinal tract in humans,and is used for the treatment of gastritis, gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome.
Mosapride report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Mosapride market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Gastritis and Dyspepsia are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Mosapride industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Mosapride key companies include Sumitomo Dainippon Pharma, Konghong Pharmaceutical, Dainippon Pharmaceutical Co., Ltd., Nihon Generic, NIPPON CHEMIPHAR CO., LTD., Lunan Pharmaceutical Group, HAOSON PHARMA, DAIICHI SANKYO and SAWAI PHARMACEUTICAL CO., LTD., etc. Sumitomo Dainippon Pharma, Konghong Pharmaceutical, Dainippon Pharmaceutical Co., Ltd. are top 3 players and held % share in total in 2022.
Mosapride can be divided into Tablet, Capsule and Others,, etc. Tablet is the mainstream product in the market, accounting for % share globally in 2022.
Mosapride is widely used in various fields, such as Gastritis, Dyspepsia and Others,, etc. Gastritis provides greatest supports to the Mosapride industry development. In 2022, global % share of Mosapride went into Gastritis filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Mosapride market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Sumitomo Dainippon Pharma
Konghong Pharmaceutical
Dainippon Pharmaceutical Co., Ltd.
Nihon Generic
NIPPON CHEMIPHAR CO., LTD.
Lunan Pharmaceutical Group
HAOSON PHARMA
DAIICHI SANKYO
SAWAI PHARMACEUTICAL CO., LTD.
Segment by Type
Tablet
Capsule
Others
Gastritis
Dyspepsia
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Mosapride market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Mosapride introduction, etc. Mosapride Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Mosapride market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Mosapride report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Mosapride market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Gastritis and Dyspepsia are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Mosapride industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Mosapride key companies include Sumitomo Dainippon Pharma, Konghong Pharmaceutical, Dainippon Pharmaceutical Co., Ltd., Nihon Generic, NIPPON CHEMIPHAR CO., LTD., Lunan Pharmaceutical Group, HAOSON PHARMA, DAIICHI SANKYO and SAWAI PHARMACEUTICAL CO., LTD., etc. Sumitomo Dainippon Pharma, Konghong Pharmaceutical, Dainippon Pharmaceutical Co., Ltd. are top 3 players and held % share in total in 2022.
Mosapride can be divided into Tablet, Capsule and Others,, etc. Tablet is the mainstream product in the market, accounting for % share globally in 2022.
Mosapride is widely used in various fields, such as Gastritis, Dyspepsia and Others,, etc. Gastritis provides greatest supports to the Mosapride industry development. In 2022, global % share of Mosapride went into Gastritis filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Mosapride market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Sumitomo Dainippon Pharma
Konghong Pharmaceutical
Dainippon Pharmaceutical Co., Ltd.
Nihon Generic
NIPPON CHEMIPHAR CO., LTD.
Lunan Pharmaceutical Group
HAOSON PHARMA
DAIICHI SANKYO
SAWAI PHARMACEUTICAL CO., LTD.
Segment by Type
Tablet
Capsule
Others
Segment by Application
Gastritis
Dyspepsia
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Mosapride market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Mosapride introduction, etc. Mosapride Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Mosapride market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.